News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Paige and Flagship Biosciences Announce Partnership to Expand Access to Immuno-Oncology Biomarker Analysis Tools
Partnership to provide access to Flagship’s AI-aided software for quantifying PD-L1 IHC stains across various tissue types NEW YORK and BROOMFIELD, COLO. — February 17,
Flagship Biosciences Listed Among 2022 Colorado Best Small Companies to Work For
Flagship Biosciences Earns Recognition as One of the Best Small Companies to Work For in Colorado January 5, 2022 // Broomfield, CO —Today, Built In
Success Through Centralization? The Path to Realizing Digital Pathology’s True Value
The Pathologist, September, 2021: Success Through Centralization? The Path to Realizing Digital Pathology’s True Value By Flagship Biosciences Team Members: Geoffrey Metcalf, Meredith James, and
Flagship Biosciences Expands Tissue Image Analysis Capabilities at New Colorado Location in Support of Pharmaceutical and Clinical Clients
Broomfield, Colorado (June 1, 2021) — Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that the company has moved its headquarters
Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment
Cambridge, Massachusetts and Westminster, Colorado (May 12, 2021) — Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and Flagship Biosciences,
Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment
Laboratory Developed Test for Manual and Image Analysis-assisted Pathologist Interpretation Westminster, Colorado and Cambridge, Massachusetts (April 12, 2021) — Flagship Biosciences, the leader in data-centric
